Related content

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

By Mazza Marianna   Squillacioti Maria Rosaria   Pecora Riccardo Daniele   Janiri Luigi   Bria Pietro  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3145-3149

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients

By Ersoy Mehmet A.   Noyan Aysin M.   Elbi Hayriye  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite

Efficacy of Topiramate in Adult Patients with Symptomatic Epilepsy: An Open-Label, Long-Term, Retrospective Observation

By Lu Yang  

CNS Drugs, Vol. 23, Iss. 4, 2009-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Tolerability and Safety of Topiramate in Chinese Patients with Epilepsy: An Open-Label, Long-Term, Prospective Study

By Lu Yang  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 683-690

Adis International

Access to resources Recommend Favorite